“The development of the novel drug, TE-1146, the CD38 specific antibody drug conjugate (ADC)” was selected as a significant case of the Center for Drug Evaluation (CDE), Taiwan.
The CDE case number is 114IDX05010.
“The development of the novel drug, TE-1146, the CD38 specific antibody drug conjugate (ADC)” was selected as a significant case of the Center for Drug Evaluation (CDE), Taiwan.
The CDE case number is 114IDX05010.